These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4618456)

  • 1. The elusive permeability barriers and binding sites for proflavine in Escherichia coli.
    Gravelle MJ; Mehta BM; Kushner DJ
    Antimicrob Agents Chemother; 1972 Jun; 1(6):470-5. PubMed ID: 4618456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of energy metabolism on the release of bound proflavine from sensitive and resistant Escherichia coli.
    Mehta BM; Gravelle MJ; Kushner DJ
    Antimicrob Agents Chemother; 1973 Sep; 4(3):332-6. PubMed ID: 4586148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proflavine Uptake and Release in Sensitive and Resistant Escherichia coli.
    Kushner DJ; Khan SR
    J Bacteriol; 1968 Oct; 96(4):1103-14. PubMed ID: 16562158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acridine binding by Escherichia coli: pH dependency and strain differences.
    Silver S; Levine E; Spielman PM
    J Bacteriol; 1968 Feb; 95(2):333-9. PubMed ID: 4867737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of osmotically stable spheroplasts from two strains of Escherichia coli ML-35, W7-M5.
    Cover WH; Baerwald RJ; Levens T
    Microbios; 1991; 67(274):23-32. PubMed ID: 1758307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Mg++ and polyamines on proflavine binding to T2 DNA.
    Riemer SC; Bloomfield VA
    Biopolymers; 1979 Jul; 18(7):1695-708. PubMed ID: 540126
    [No Abstract]   [Full Text] [Related]  

  • 7. Nucleic acid binding drugs. Part XIII. Molecular motion in a drug-nucleic acid model system: thermal motion analysis of a proflavine-dinucleoside crystal structure.
    Aggarwal AK; Neidle S
    Nucleic Acids Res; 1985 Aug; 13(15):5671-84. PubMed ID: 4034394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RESISTANCE AND CROSS-RESISTANCE OF ESCHERICHIA COLI S MUTANTS TO THE RADIOMIMETIC AGENT PROFLAVINE.
    WOODY-KARRER P; GREENBERG J
    J Bacteriol; 1964 Mar; 87(3):536-42. PubMed ID: 14129667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of resistance to proflavine and penicillin in Escherichia coli.
    McKellar RC; McKenzie CN; Kushner KJ
    Antimicrob Agents Chemother; 1976 Oct; 10(4):765-7. PubMed ID: 791110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acriflavine uptake and resistance in Serratia marcescens cells and spheroplasts.
    Woods DR; Schauder VR; Waddington PB
    J Bacteriol; 1973 Apr; 114(1):59-64. PubMed ID: 4572726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence decay and quantum yield characteristics of acridine orange and proflavine bound to DNA.
    Kubota Y; Steiner RF
    Biophys Chem; 1977 Apr; 6(3):279-89. PubMed ID: 880342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of formulation on the percutaneous absorption of proflavine hemisulphate.
    Selkirk AB; Dolder R
    Pharm Acta Helv; 1976; 51(6):160-3. PubMed ID: 959240
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative study of DNA interactions with daunomycin and proflavine in a solution].
    Veselkov AN; Moroshkina EB; Soboleva OI; Frisman EV
    Mol Biol (Mosk); 1984; 18(2):481-7. PubMed ID: 6717424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proflavine binding and release by sensitive and resistant Bacillus subtilis.
    Barabas G; Mehta BM; Kushner DJ
    Can J Microbiol; 1970 Oct; 16(10):973-81. PubMed ID: 4991782
    [No Abstract]   [Full Text] [Related]  

  • 15. 'Petite' mutagenesis in Saccharomyces cerevisiae by a series of 2,7-di-alkyl-substituted derivatives of proflavine with differing DNA-binding properties.
    Ferguson LR; Denny WA; Feigon J
    Mutat Res; 1988 Sep; 201(1):213-8. PubMed ID: 3047573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibition of ribonucleic acid polymerase by acridines.
    Nicholson BH; Peacocke AR
    Biochem J; 1966 Jul; 100(1):50-8. PubMed ID: 4290534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of proflavin binding to bacteriophages T2L and T4D.
    McCall PJ; Bloomfield VA
    Biopolymers; 1976 Dec; 15(12NA-NA-770103-770104):2323-36. PubMed ID: 1000044
    [No Abstract]   [Full Text] [Related]  

  • 18. Flow cytometric analysis of proflavine uptake into normal rat hepatocytes and cells arising during AAF-induced hepatocarcinogenesis.
    Austin EB; Holmes CH; Robins RA; Baldwin RW
    Carcinogenesis; 1984 Sep; 5(9):1173-7. PubMed ID: 6467506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence specificity of mutagen-nucleic acid complexes in solution: intercalation and mutagen-base pair overlap geometries for proflavine binding to dC-dC-dG-dG and dG-dG-dC-dC self-complementary duplexes.
    Patel DJ; Canuel LL
    Proc Natl Acad Sci U S A; 1977 Jul; 74(7):2624-8. PubMed ID: 268613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantum chemical calculations on the two-step mechanism of proflavin binding to DNA.
    Pack GR; Hashimoto GM; Loew GH
    Ann N Y Acad Sci; 1981; 367():240-9. PubMed ID: 6942753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.